All In MedTech

Device Trial Radar · NCT05536310

TAVIS Registry - Trilogy Heart Valve System for Management of Patients With Aortic Valve Disease

Trilogy Heart Valve System for Management of Patients With Aortic Valve Disease: Patient Registry

Last checked: Nov 20, 2026Latest source record: Aug 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

24

Actual

Start

Aug 1, 2023

Primary completion

Jul 9, 2024

Study completion Jul 9, 2024

Sponsor

Lead sponsor
JenaValve Technology, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Sep 10, 2022

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To collect information about the management of symptomatic severe Aortic Stenosis (AS) and Aortic Regurgitation (AR) using transcatheter aortic valve replacement (TAVI).

Conditions

  • Aortic Valve Stenosis
  • Aortic Valve Regurgitation
  • Aortic Valve Stenosis With Insufficiency
  • Constriction, Pathologic
  • Aortic Valve Disease
  • Heart Valve Diseases
  • Cardiovascular Diseases in Old Age
  • Ventricular Outflow Obstruction
  • Aortic Stenosis, Severe

Interventions

  • Transcatheter Aortic Valve Implantation (TAVI)Device

    TAVI with the JenaValve Trilogy Heart Valve System

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. All-cause mortalityTime frame: 30-days post-index procedure

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Herz-und Diabeteszentrum NRW Ruhr-Universität Bochum Bad Oeynhausen

    Bad Oeynhausen, Germany

  • University Hospital of Cologne Heart Center

    Cologne, Germany

  • University Hospital Mainz

    Mainz, Germany

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.